IBOV 169,816.64 ▲ 0.31% IPC MEX 71,425.95 ▲ 0.31% MERVAL 2,848,945 — — USD/BRL5.77▼ 0.31% USD/MXN18.40▼ 0.64% USD/CLP992.33▼ 0.72% USD/COP3,302▼ 0.49% USD/PEN3.41▲ 0.12% USD/ARS1,552▲ 0.14% USD/UYU40.61▲ 3.40% USD/PYG6,212▲ 3.22% USD/BOB11.64▲ 2.89% USD/DOP60.08▲ 1.61% USD/CRC441.73▲ 1.57% USD/GTQ7.64▲ 3.17% USD/HNL26.89▲ 2.99% USD/NIO36.62▲ 2.50% USD/VES913.46▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.30▲ 2.54% USD/TTD6.70▲ 1.69% EUR/BRL6.35▲ 1.76% BRENT 93.07 ▲ 0.68% WTI 85.61 ▼ 0.13% IRON ORE 161.91 — — COPPER 6.00 ▼ 0.04% GOLD 3,852 ▼ 0.03% SILVER 47.29 ▲ 1.08% SOY 1,226 ▼ 0.28% CORN 446.75 ▼ 0.45% WHEAT 610.25 ▲ 3.96% COFFEE 279.95 ▼ 0.27% SUGAR 18.17 ▲ 0.39% ORANGE JUICE 133.75 ▼ 1.76% COTTON 81.30 ▲ 5.58% COCOA 5,184 ▲ 2.82% BEEF 222.80 ▲ 1.12% CATTLE 327.90 ▼ 2.81% LITHIUM 56.42 ▼ 0.74% PETR4 43.98 ▼ 0.09% VALE3 60.34 ▼ 0.59% ITUB4 40.89 ▼ 0.99% BBDC4 14.41 ▲ 1.26% ABEV3 15.93 ▲ 0.38% BBAS3 14.62 ▼ 2.21% B3SA3 14.65 ▼ 1.08% WEGE3 51.15 ▲ 1.49% PRIO3 63.96 ▲ 2.12% SUZB3 55.39 ▼ 0.20% RENT3 29.66 ▲ 1.19% AZZA3 15.64 ▼ 3.10% CSAN3 3.25 ▲ 5.18% RAIZ4 19.11 ▼ 4.45% PCAR3 2.89 ▲ 11.15% GMAT3 4.18 ▲ 1.21% PSSA3 45.92 ▲ 0.83% CVCB3 0.78 ▼ 1.27% POSI3 3.13 ▲ 0.97% SLCE3 18.06 ▲ 1.18% NATU3 4.75 ▼ 3.06% BRKM5 2.75 ▼ 3.17% RANI3 8.22 ▲ 0.37% CSNA3 3.77 ▲ 2.45% IBOV 169,816.64 ▲ 0.31% IPC MEX 71,425.95 ▲ 0.31% MERVAL 2,848,945 — — USD/BRL 5.78 ▼ 0.10% USD/MXN 18.41 ▼ 0.56% USD/CLP 992.33 ▼ 0.72% USD/COP 3,299 ▼ 0.58% USD/PEN 3.41 ▲ 0.12% USD/ARS 1,552 ▲ 0.14% USD/UYU 40.61 ▲ 3.40% USD/PYG 6,212 ▲ 3.22% USD/BOB 11.64 ▲ 2.89% USD/DOP 60.08 ▲ 1.61% USD/CRC 441.73 ▲ 1.57% USD/GTQ 7.64 ▲ 3.17% USD/HNL 26.89 ▲ 2.99% USD/NIO 36.62 ▲ 2.50% USD/VES 913.46 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.30 ▲ 2.54% USD/TTD 6.70 ▲ 1.69% EUR/BRL 6.35 ▲ 1.85% BRENT 93.07 ▲ 0.68% WTI 85.61 ▼ 0.13% IRON ORE 161.91 — — COPPER 6.00 ▼ 0.04% GOLD 3,852 ▼ 0.03% SILVER 47.29 ▲ 1.08% SOY 1,226 ▼ 0.28% CORN 446.75 ▼ 0.45% WHEAT 610.25 ▲ 3.96% COFFEE 279.95 ▼ 0.27% SUGAR 18.17 ▲ 0.39% ORANGE JUICE 133.75 ▼ 1.76% COTTON 81.30 ▲ 5.58% COCOA 5,184 ▲ 2.82% BEEF 222.80 ▲ 1.12% CATTLE 327.90 ▼ 2.81% LITHIUM 56.42 ▼ 0.74% PETR4 43.98 ▼ 0.09% VALE3 60.34 ▼ 0.59% ITUB4 40.89 ▼ 0.99% BBDC4 14.41 ▲ 1.26% ABEV3 15.93 ▲ 0.38% BBAS3 14.62 ▼ 2.21% B3SA3 14.65 ▼ 1.08% WEGE3 51.15 ▲ 1.49% PRIO3 63.96 ▲ 2.12% SUZB3 55.39 ▼ 0.20% RENT3 29.66 ▲ 1.19% AZZA3 15.64 ▼ 3.10% CSAN3 3.25 ▲ 5.18% RAIZ4 19.11 ▼ 4.45% PCAR3 2.89 ▲ 11.15% GMAT3 4.18 ▲ 1.21% PSSA3 45.92 ▲ 0.83% CVCB3 0.78 ▼ 1.27% POSI3 3.13 ▲ 0.97% SLCE3 18.06 ▲ 1.18% NATU3 4.75 ▼ 3.06% BRKM5 2.75 ▼ 3.17% RANI3 8.22 ▲ 0.37% CSNA3 3.77 ▲ 2.45%
since 2009
Tuesday, November 17, 2026

Africa Ghana

Ghana Medical Fund Explores Hungary Health Tie-Up

By · · 5 min read
Kumasi city view Ghana
Kumasi, Ghana’s second city, which has the main referral hospital outside the capital (Photo: Maven Egote, CC BY-SA 4.0 via Wikimedia Commons)

Key Facts

  • What happened Ghana Medical Trust Fund Administrator Adjoa Obuobia Darko-Opoku met Hungary’s ambassador Tamas Endre Feher to discuss cooperation on medical equipment, hospital technology and infrastructure.
  • The money Ghana’s 2025 budget allocated GH¢9.9 billion (about US$845 million at current rates) to National Health Insurance Scheme priorities, including Mahama Cares.
  • The Fund’s allocation A later government allocation reported for the Ghana Medical Trust Fund was GH¢2.1 billion (about US$180 million at current rates).
  • Who it helps Patients with cancer, diabetes, cardiovascular disease, chronic kidney failure and stroke whose costs are not covered by Ghana’s National Health Insurance Scheme.
  • What comes next No signed agreement, contract value or delivery timetable exists yet; the discussions remain exploratory.

The Ghana Medical Trust Fund and Hungary are exploring a partnership to strengthen specialised healthcare through medical equipment, hospital technology and infrastructure. The talks could give Hungarian manufacturers a foothold in Ghana’s expanding health sector.

Free daily brief — no card needed
Get every Africa story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Ghana’s Medical Trust Fund (GMTF) and Hungary are exploring cooperation to expand specialised healthcare, including medical equipment, hospital technology and infrastructure. The discussions followed a meeting between GMTF Administrator Adjoa Obuobia Darko-Opoku and Hungary’s ambassador to Ghana, Tamas Endre Feher.

What the Ghana Medical Trust Fund partnership covers

Ambassador Feher offered to connect the Fund with Hungarian medical-equipment manufacturers. The proposal aligns with the Fund’s domestic-care mandate of supporting approved patients with costly chronic diseases, strengthening hospitals, training specialist staff and financing relevant research.

President John Dramani Mahama launched the GMTF, also called Mahama Cares, in April 2025. Eligible conditions include cancer, diabetes, cardiovascular disease, chronic kidney failure and stroke.

Support targets costs not covered by Ghana’s National Health Insurance Scheme (NHIS).

Volta Region, Ghana
File photo: Volta Region, Ghana

Where the money comes from

The Fund’s principal financing source is the uncapped component of the National Health Insurance Levy. It is supplemented by government budget support, donations, grants, voluntary corporate contributions and investment income.

Ghana’s 2025 budget allocated GH¢9.9 billion (about US$845 million at current rates) to NHIS-related priorities, including claims, medicines, vaccines, free primary healthcare and Mahama Cares. A later government allocation reported for the Fund was GH¢2.1 billion (about US$180 million at current rates).

These figures show the scale of public financing behind the health agenda. The Hungarian discussions could channel some of that spending toward European medical technology.

The commercial and geopolitical stakes

Ghana needs diagnostic capacity and specialist infrastructure while seeking to reduce expensive overseas treatment and dependence on imported health products. Hungary would gain an entry point for its medical-equipment industry and a visible role in Ghana’s health-sector development.

The proposal combines Ghanaian public-health financing with European technology and industrial diplomacy. It fits a broader pattern of middle powers seeking influence in African health markets.

For context on how such partnerships fit into wider competition for African resources and infrastructure, see Africa: The New Scramble.

What the Ghana Medical Trust Fund does today

The Fund supports patients with chronic conditions that impose heavy financial burdens on households. Its focus on cancer, diabetes, cardiovascular disease, chronic kidney failure and stroke reflects Ghana’s rising non-communicable disease burden.

By financing hospital upgrades and specialist training, the Fund aims to build long-term domestic capacity. The Hungarian talks could accelerate that goal if they move beyond exploration.

No signed agreement, contract value or delivery timetable exists yet. Both sides have described the discussions as exploratory.

What to watch next

The next signal will be whether the Fund and Hungarian manufacturers move to formal technical discussions. Any memorandum of understanding or procurement framework would mark a step forward.

Ghanaian officials have not announced a timeline for follow-up meetings. Investors and health-sector suppliers should monitor GMTF announcements for equipment tenders or pilot projects.

The Fund’s GH¢2.1 billion (about US$179 million) allocation gives it meaningful purchasing power.

Why does the National Health Insurance Scheme not cover these treatments?

Ghana’s National Health Insurance Scheme was designed around common, high-volume care, and its benefit package has historically excluded or capped the most expensive treatments. Cancer chemotherapy, dialysis for chronic kidney failure and long-term stroke rehabilitation are the clearest examples: they cost far more per patient than the scheme’s standard reimbursement rates, so hospitals often ask patients to pay out of pocket.

That gap is the reason the Ghana Medical Trust Fund exists. Its mandate covers patients with cancer, diabetes, cardiovascular disease, chronic kidney failure and stroke whose costs the insurance scheme does not carry, and the meeting with Hungary’s ambassador fits the same logic, looking for equipment and technology partners rather than cash alone.

Frequently Asked Questions

What is the Ghana Medical Trust Fund?

The Ghana Medical Trust Fund, also called Mahama Cares, is a public fund launched in April 2025 to support patients with costly chronic diseases and strengthen hospitals, specialist training and research.

Which conditions does the Ghana Medical Trust Fund cover?

Eligible conditions include cancer, diabetes, cardiovascular disease, chronic kidney failure and stroke, focusing on costs not covered by Ghana’s National Health Insurance Scheme.

Has Ghana signed an agreement with Hungary on healthcare?

No signed agreement, contract value or delivery timetable exists yet; the discussions between the Fund and Hungary’s ambassador remain exploratory.

RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Connected Coverage

Sources

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.